全文获取类型
收费全文 | 10107951篇 |
免费 | 630256篇 |
国内免费 | 161252篇 |
专业分类
耳鼻咽喉 | 130766篇 |
儿科学 | 282325篇 |
妇产科学 | 231698篇 |
基础医学 | 1253802篇 |
口腔科学 | 264507篇 |
临床医学 | 1022440篇 |
内科学 | 1697028篇 |
皮肤病学 | 203717篇 |
神经病学 | 730372篇 |
特种医学 | 377177篇 |
外国民族医学 | 1661篇 |
外科学 | 1330611篇 |
综合类 | 706274篇 |
现状与发展 | 513篇 |
一般理论 | 3725篇 |
预防医学 | 811366篇 |
眼科学 | 230353篇 |
药学 | 864598篇 |
2777篇 | |
中国医学 | 209964篇 |
肿瘤学 | 543785篇 |
出版年
2023年 | 53705篇 |
2022年 | 131412篇 |
2021年 | 200441篇 |
2020年 | 143170篇 |
2019年 | 146060篇 |
2018年 | 178123篇 |
2017年 | 158463篇 |
2016年 | 152510篇 |
2015年 | 189363篇 |
2014年 | 277343篇 |
2013年 | 369010篇 |
2012年 | 521956篇 |
2011年 | 566046篇 |
2010年 | 383462篇 |
2009年 | 345034篇 |
2008年 | 482039篇 |
2007年 | 502355篇 |
2006年 | 479590篇 |
2005年 | 441580篇 |
2004年 | 388492篇 |
2003年 | 360141篇 |
2002年 | 332019篇 |
2001年 | 312118篇 |
2000年 | 310750篇 |
1999年 | 266241篇 |
1998年 | 111123篇 |
1997年 | 97680篇 |
1996年 | 91665篇 |
1995年 | 83757篇 |
1994年 | 75905篇 |
1993年 | 64897篇 |
1992年 | 182878篇 |
1991年 | 176916篇 |
1990年 | 171623篇 |
1989年 | 166576篇 |
1988年 | 153999篇 |
1987年 | 150069篇 |
1986年 | 142884篇 |
1985年 | 136140篇 |
1984年 | 103672篇 |
1983年 | 89014篇 |
1982年 | 56693篇 |
1979年 | 93075篇 |
1978年 | 66790篇 |
1977年 | 57600篇 |
1975年 | 58440篇 |
1974年 | 67411篇 |
1973年 | 64327篇 |
1972年 | 59451篇 |
1971年 | 55078篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Collagens are the most abundant proteins in the extracellular matrix. They provide a framework to build organs and tissues and give structural support to make them resistant to mechanical load and forces. Several intra‐ and extracellular modifications are needed to make functional collagen molecules, intracellular post‐translational modifications of proline and lysine residues having key roles in this. In this article, we provide a review on the enzymes responsible for the proline and lysine modifications, that is collagen prolyl 4‐hydroxylases, 3‐hydroxylases and lysyl hydroxylases, and discuss their biological functions and involvement in diseases. 相似文献
4.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
5.
6.
7.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
8.
9.
10.
Anela Stanic Denis Rybin Francis Cannata Carole Hohl Jennifer Brody Jessie Gaeta 《AIDS care》2021,33(1):1-9
ABSTRACT The lack of stable housing can impair access and continuity of care for patients living with human immunodeficiency virus (HIV). This study investigated the relationship between housing status assessed at multiple time points and several core HIV-related outcomes within the same group of HIV patients experiencing homelessness. Patients with consistently stable housing (CSH) during the year were compared to patients who lacked CSH (non-CSH group). The study outcomes included HIV viral load (VL), CD4 counts, and health care utilization. Multivariable and propensity weighted analyses were used to assess outcomes adjusting for potential group differences. Of 208 patients, 88 (42%) had CSH and 120 (58%) were non-CSH. Patients with CSH had significantly higher proportion of VL suppression and higher mean CD4 counts. The frequency of nurse visits in the CSH group was less than a half of that in the non-CSH group. Patients with CSH were less likely to be admitted to the medical respite facility, and if admitted, their length of stay was about a half of that for the non-CSH group. Our study findings show that patients with CSH had significantly better HIV virologic control and immune status as well as improved health care utilization. 相似文献